“…The study types included randomized trials (n = 1), pilot studies (n = 2), prospective cohort studies (n = 4), retrospective review (n = 2), retrospective cohort study (n = 2), retrospective observational pre-post study (n=1), prospective quasi-experimental study (n = 1), and case study (n=1). Participants of the included studies contained patients with hypertension, diabetes, and/or dyslipidemia (n = 2) 3,5 ; heart failure (n = 4) [6][7][8][9] ; cystic fibrosis (n = 2) 4,10 ; cancer (n = 1) 11 ; chronic obstructive pulmonary disease (n = 1) 10 ; veterans with varying mental health disorders (n = 2) 12,13 ; elective surgical patients (n = 1) 14 ; patients requiring warfarin therapy (n = 1) 5 ; and patients with varying or multiple chronic diseases requiring management (n = 2). 15,16 In the studies reviewed, pharmacist telehealth monitoring was conducted via phone (n = 8), 3,4,6,8,10,[14][15][16] video conferencing (n = 3), 4,9,13 both teleconferencing software and phone (n = 2), 7,11 e-charts (n = 1), 5 and tablet (n = 1).…”